-+ 0.00%
-+ 0.00%
-+ 0.00%
CONMED Q3 net income rises to $19.8 million; Q3 net sales fall to $335.6 million
Share
Listen to the news
CONMED Q3 net income rises to $19.8 million; Q3 net sales fall to $335.6 million
  • CONMED’s third-quarter 2026 diluted earnings rose to $0.66 per share, while net sales fell to $335.6 million year-over-year.
  • The AirSeal Robotic Solution gained an indication for use with Intuitive’s 8 mm hex cannulas for the da Vinci 5 platform.
  • Full-year 2026 net sales guidance narrowed to $1.36 billion–$1.37 billion.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CONMED Corporation published the original content used to generate this news brief via Business Wire (Ref. ID: 202610281605BIZWIRE_USPR_____20261028_BW500171) on October 28, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending